Cibc World Markets Corp Acquires 925 Shares of Teleflex Incorporated (NYSE:TFX)

Cibc World Markets Corp grew its stake in shares of Teleflex Incorporated (NYSE:TFX) by 14.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 7,340 shares of the medical technology company’s stock after purchasing an additional 925 shares during the quarter. Cibc World Markets Corp’s holdings in Teleflex were worth $1,306,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of TFX. Vontobel Holding Ltd. grew its position in Teleflex by 21.9% during the 4th quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock worth $248,000 after acquiring an additional 250 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in shares of Teleflex by 14.3% in the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after buying an additional 5,322 shares during the period. Lecap Asset Management Ltd. purchased a new position in shares of Teleflex in the fourth quarter worth $729,000. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Teleflex by 35.1% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock valued at $1,053,000 after buying an additional 1,527 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

TFX opened at $141.77 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market cap of $6.57 billion, a price-to-earnings ratio of 28.19, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The stock has a fifty day simple moving average of $163.17 and a two-hundred day simple moving average of $194.40. Teleflex Incorporated has a 12-month low of $128.55 and a 12-month high of $249.91.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.96%. Teleflex’s payout ratio is currently 95.77%.

Analyst Ratings Changes

Several equities analysts have recently commented on TFX shares. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Morgan Stanley dropped their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a report on Wednesday, March 5th. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Finally, Truist Financial reduced their price objective on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a research report on Monday, March 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Teleflex currently has an average rating of “Hold” and a consensus price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.